A carregar...

Overcoming Resistance to HER2 Inhibitors Through State-Specific Kinase Binding

The heterodimeric receptor tyrosine kinase complex formed by HER2 and HER3 can act as an oncogenic driver and is also responsible for rescuing a large number of cancers from a diverse set of targeted therapies. Current inhibitors of these proteins, particularly HER2, have dramatically improved patie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Chem Biol
Main Authors: Novotny, Chris J., Pollari, Sirkku, Park, Jin H., Lemmon, Mark A., Shen, Weijun, Shokat, Kevan M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5069157/
https://ncbi.nlm.nih.gov/pubmed/27595329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nchembio.2171
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!